T cells

Autolomous and Vineti form strategic partnership to deliver end to end supply chain management solutions for cell and gene therapy sector

Autolomous LTD, the market leading developer of critical manufacturing management systems for cell and gene therapies, and Vineti, a provider of leading digital enterprise platforms for cell and gene therapy supply chains, today announce a non-exclusive collaborative partnership.

Read More
May 15, 2019

Supply chain management readiness, Part 2: operational ecosystem

(Note: this post is the second part of a four-part series on supply chain planning for personalized therapies such as...

May 2, 2019

Commercial lessons for clinical-phase success, Part I: it all starts with collaboration

In early-phase clinical research, it’s common to think that your science resides within your lab. But when it comes to...

April 24, 2019

Supply chain management readiness, Part 1: strategy

There are many critical decisions to be made when moving a large-molecule biologic out of the lab into human trials....